hat
Mirabegron (non komès Myrbetriq meer-bet-trick nan US la ak Betmiga nan Ewòp) se yon dwòg pou tretman an nan blad pipi aktif. Li te devlope pa Astellas Pharma e li te apwouve nan peyi Etazini nan Jiyè 2012.Yon Tags: Hydroxyprogesterone Caproate .
eng
Mirabegron (trade name Myrbetriq meer-bet-trick in the US and Betmiga in Europe) is a drug for the treatment of overactive bladder. It was developed by Astellas Pharma and was approved in the United States in July 2012.Hot tags: Hydroxyprogesterone Caproate .